Sjogrens Syndrome Measured by Ultrasound
Sjogrens Syndrome Measured by Ultrasound
Ultrasound study focused on salivary gland outcomes in Sjogren's subjects
A 32 week ultrasound study for subject diagnosed with Sjogren's Syndrome. Subjects will
 receive Orencia (Abatacept) as intervention therapy during this trial.
Inclusion Criteria:

 -  Subjects diagnosed with Sjogren's Syndrome

 Exclusion Criteria:

 -  Subjects previously diagnosed with Sarcoidsis

 -  Subjects with positive for Hepatitis B, Hepatitis C, HIV

 -  Subjects diagnosed with Cancer within 5 years of screening